So yesterday, so it was my appointment with my neurologist at Nantes, I waited with great impatience. Well, a bit of disappointment for the answers I expected, he'll have to wait a bit ... He can not help me with the mystery of the failure of the toxin botulinum, it is "not sufficiently expert in this field" ...
Concerning a problem "second tier", but still important to me migraines. Beta-blockers were still pretty effective as maintenance treatment, since the number of crisis had diminished. But they are absolutely cons-indicated in combination with Mexitil, which treats myotonias. So we tried the last thing left to try: the tricyclic antidepressants. As this would be a shame to spoil the school, he prescribed the Cymbalta, which is one of the few to have no sedative effect. For
the channelopathy, nothing new, I just learned that genetic research that was launched was much largeque what I understood, with one hand ion channel analysis, and other analysis of genetic abnormalities responsible for progressive external ophthalmoplegia , in particular, mitochondrial citopathies .
To return to the botulinum toxin, the idea of a malformation of the neuromuscular junction is eliminated according to him, just as if this were the case, botulinum toxin would have been disastrous. We can not say she was ... He then told me to take appointment with Pr Pereon center rare neuromuscular disease, which is stalled on it. A little more waiting until June 30
Finally, do not stop there way visit to the optometrist on Monday in Toulouse.
0 comments:
Post a Comment